October 18, 2023
LSL Pharma Group Announces Exclusive Distribution Agreement With Fera Pharmaceuticals To Alleviate Drug Shortage In U.S. HospitalsJune 01, 2022
Fera Pharmaceuticals is launching Phospholine Iodide® June 1st!April 11, 2022
Fera Pharmaceuticals Announces FDA Orphan Designation for Phospholine Iodide® for the Treatment of Stargardt DiseaseMarch 02, 2022
Fera Obtains Orphan Drug Designation for Naproxcinod for the Treatment of Sickle Cell DiseaseFebruary 09, 2022
Fera announces it has executed an agreement for the long-term manufacturing of Phospholine Iodide®️August 04, 2021
Fera Pharmaceuticals is pleased to announce that it has completed an agreement with Pfizer to acquire Phospholine Iodide®August 07, 2020
Fera Announces the Launch of Dexamethasone 4 mg Tablets in Unit Dose PackagingApril 01, 2019
Fera Pharmaceuticals Announces FDA Approval of AvaclyrTM (acyclovir ophthalmic ointment)